[{"Assets_0_FY_USD":203533559.0,"CommonStockSharesOutstanding_0_FY_shares":56279307.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-131240797.0,"NetIncomeLoss_4_FY_USD":-127502194.0,"NetIncomeLoss_1_FY_USD":-36459475.0,"StockholdersEquity_0_FY_USD":160972655.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190226"}]